Windfall for Mediclinic execs — despite 70% share slump
Rewards continue to roll into the C-suite despite disappointing company performance and evaporating shareholder value
Investors are a funny bunch. Private hospital group Mediclinic International’s disappointing offshore ventures have meant it has shed more than 70% of its value in the past three years while its senior executives continued to get generous bonuses with barely a murmur from shareholders.
But there is growing disquiet among a minority of institutional investors, and the company may face tough questions at its AGM later this month.